Antoine Yver - May 27, 2021 Form 4 Insider Report for Centessa Pharmaceuticals plc (CNTA)

Role
Chief Medical Officer
Signature
/s/ Marella Thorell, attorney-in-fact
Stock symbol
CNTA
Transactions as of
May 27, 2021
Transactions value $
$0
Form type
4
Date filed
6/1/2021, 08:48 PM
Next filing
Feb 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CNTA Ordinary Shares Award $0 +834K $0.00 834K May 27, 2021 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents A Ordinary Shares that will be redesignated as Ordinary Shares immediately prior to the closing of the initial public offering.
F2 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F3 The shares are subject to a right of repurchase by the Issuer, which vest as follows: 25% of the shares will vest on May 17, 2022 and the remaining 75% of the shares will vest in 36 monthly installments on the first day of each month thereafter.